Amplia Therapeutics Ltd.ASX: ATX

Amplia to Raise up to $13m for ACCENT and US Trials

· Issued by Amplia Therapeutics Ltd.

Filed with ASX · · 7 pages · English

Summary by 6ix AI

The company aims to raise up to a specified amount through a combination of an entitlement offer, an institutional placement, and a director placement. The funds will be used for trial costs and general working capital, with new shares priced at a specific amount each. The capital raise is expected to issue a significant number of new shares, representing a notable percentage of the company's current shares on issue.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Amplia Therapeutics Ltd. on 6ix

In the deck

Story so far

Earlier from Amplia Therapeutics

Later from Amplia Therapeutics

All Amplia Therapeutics news releases